<DOC>
	<DOCNO>NCT02942576</DOCNO>
	<brief_summary>There insufficient data safety efficacy edoxaban therapy subject AF follow catheter ablation . This phase 3b study design evaluate safety explore efficacy edoxaban-based antithrombotic regimen versus VKA-based antithrombotic regimen subject AF follow catheter ablation . Bleeding central safety outcome cardiovascular clinical trial , especially antithrombotic strategy invasive procedure .</brief_summary>
	<brief_title>Edoxaban Treatment Versus Vitamin K Antagonist ( VKA ) Patients With Atrial Fibrillation ( AF ) Undergoing Catheter Ablation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<mesh_term>Phenprocoumon</mesh_term>
	<mesh_term>Acenocoumarol</mesh_term>
	<criteria>Male female least 18 year age document history paroxysmal ( last ≤7 day ) , persistent ( last &gt; 7 day ≤12 month ) longstanding [ longlasting ] persistent ( &gt; 12 month ) nonvalvular AF . Duration AF confirm electrical tracing record subject 's medical record ( e.g. , medical chart , hospital discharge summary ) . Subject eligible schedule either radio frequency ( RF ) cryoballoon catheter ablation ( first repeat procedure include ) . Signed informed consent form ( ICF ) . AF consider transient reversible nature ( myocarditis , postsurgery , ionic disturbance , thyrotoxicosis , pneumonia , severe anemia etc. ) . Subject post stroke , systemic thromboembolic event within past 6 month prior randomization . Subject thrombus leave atrial appendage ( LAA ) , leave atrium ( LA ) , leave ventricle ( LV ) , aorta , intracardial mass . Subject myocardial infarction ( MI ) within 2 month prior randomization coronary artery bypass graft ( CABG ) surgery within 3 month prior randomization . Subject sign bleeding , history clinicallyrelevant bleed accord ISTH , condition associate high risk bleed Subjects contraindication anticoagulant agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>